HIGH-DOSE INACTIVATED INFLUENZA VACCINE IS ASSOCIATED WITH COST SAVINGS AND BETTER OUTCOMES COMPARED TO STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN SENIORS

被引：0
|
作者：
Chit, A. [1 ]
Becker, D. L. [2 ]
Diazgranados, C. [1 ]
Maschio, M. [3 ]
Yau, E. [1 ]
Drummond, M. [4 ]
机构：
[1] Sanofi Pasteur, Swiftwater, PA USA
[2] Optum, Burlington, ON, Canada
[3] OptumInsight, Burlington, ON, Canada
[4] Univ York, York YO10 5DD, N Yorkshire, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1399
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN75
引用
收藏
页码：A240 / A240
页数：1
相关论文
共 50 条
  • [31] Fluzone® High-Dose Influenza Vaccine
    Robertson, Corwin A.
    DiazGranados, Carlos A.
    Decker, Michael D.
    Chit, Ayman
    Mercer, Monica
    Greenberg, David P.
    EXPERT REVIEW OF VACCINES, 2016, 15 (12) : 1495 - 1505
  • [32] Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness Comparison of High-dose Versus Standard-dose Vaccines
    Butler, Anne M.
    Layton, J. Bradley
    Krueger, Whitney S.
    Kshirsagar, Abhijit V.
    McGrath, Leah J.
    MEDICAL CARE, 2019, 57 (01) : 73 - 78
  • [33] Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis
    Butler, Anne M.
    Layton, J. Bradley
    Dharnidharka, Vikas R.
    Sahrmann, John M.
    Seamans, Marissa J.
    Weber, David J.
    McGrath, Leah J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (01) : 72 - 83
  • [34] Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
    Hansen, John
    Goddard, Kristin
    Timbol, Julius
    Zhang, Lea
    Lewis, Ned
    Dunkle, Lisa
    Izikson, Ruvim
    Klein, Nicola P.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (06):
  • [35] Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial
    Jamshed, Saad
    Walsh, Edward E.
    Dimitroff, Lynda J.
    Santelli, Jeanine Seguin
    Falsey, Ann R.
    VACCINE, 2016, 34 (05) : 630 - 635
  • [36] An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
    Fochesato, Anna
    Sottile, Sara
    Pugliese, Andrea
    Marquez-Pelaez, Sergio
    Toro-Diaz, Hector
    Gani, Ray
    Alvarez, Piedad
    Ruiz-Aragon, Jesus
    VACCINES, 2022, 10 (08)
  • [37] High-Dose Inactivated Influenza Vaccine Inconsistently Improves Heterologous Antibody Responses in an Older Human Cohort
    Billings, W. Zane
    Ge, Yang
    Knight, Jessica H.
    Hemme, Hayley
    Hammerton, Savannah M.
    Skarlupka, Amanda L.
    Cao, Wangnan
    Shen, Ye
    Bahl, Justin
    Thomas, Paul G.
    Ross, Ted M.
    Handel, Andreas
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [38] Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season
    Bahakel, Hannah
    Spieker, Andrew J.
    Hayek, Haya
    Schuster, Jennifer E.
    Hamdan, Lubna
    Dulek, Daniel E.
    Kitko, Carrie L.
    Stopczynski, Tess
    Batarseh, Einas
    Haddadin, Zaid
    Stewart, Laura S.
    Stahl, Anna
    Potter, Molly
    Rahman, Herdi
    Amarin, Justin
    Kalams, Spyros A.
    Bocchini, Claire E.
    Moulton, Elizabeth A.
    Coffin, Susan E.
    Ardura, Monica, I
    Wattier, Rachel L.
    Maron, Gabriela
    Grimley, Michael
    Paulsen, Grant
    Harrison, Christopher J.
    Freedman, Jason
    Carpenter, Paul A.
    Englund, Janet A.
    Munoz, Flor M.
    Danziger-Isakov, Lara
    Halasa, Natasha
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [39] Randomized study comparing high-dose (HD) influenza vaccine to standard-dose (SD) influenza vaccine in patients with breast cancer age < 65 receiving chemotherapy.
    Jamshed, Saad
    Falsey, Ann R.
    Thushara, Paul
    Walker, Jennifer
    Walsh, Edward E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND
    Gibbons, I
    Davidson, C.
    Clark-Wright, J.
    Miller, C.
    Carroll, S.
    Costa, M.
    Bricout, H.
    Alvarez, F. P.
    VALUE IN HEALTH, 2020, 23 : S554 - S554
12345